Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy

Author(s): Rajeev Sharma, Nishi Mody, Udita Agrawal, S. P. Vyas*

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 17 , Issue 18 , 2017

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


In the recent years, theranostic nanomedicine based strategies have gained much attention in the field of oncology particularly, in the development of new generation cancer diagnostic and therapeutic tools. Today, various approaches have been developed for bioactive(s) targeting to predefined pathological sites, as well as for quantification of physiological processes and visualization. Significant attempts have been made to combine therapeutic and diagnostic properties in to a single effective nanomedicine formulation. This concept, coined as “theranostics” is smart nanosystem(s), able to diagnose, bioactive(s) delivery and monitoring of therapeutic response. By combining therapeutic functionalities with molecular imaging, theranostic based strategies may be beneficial in the selection of therapy, planning of treatment, monitoring of objective response and planning of follow-up therapy based on the specific molecular characteristics of a disease. In this manuscript, we reviewed the recent development of theranostic approaches, various nanosystems as theranostic agents and applications of theranostic in cancer therapeutics and diagnostics.

Keywords: Bioactive(s) delivery, cancer, chemotherapeutics, nanomedicine, theranostics, WHO.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 07 November, 2017
Page: [1746 - 1757]
Pages: 12
DOI: 10.2174/1389557516666160219122524
Price: $65

Article Metrics

PDF: 42
PRC: 1